LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 72 filers reported holding LOXO ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $319,496,000 | -17.7% | 2,280,968 | +0.4% | 0.02% | -5.9% |
| Q3 2018 | $388,029,000 | +6.8% | 2,271,428 | +8.4% | 0.02% | 0.0% |
| Q2 2018 | $363,468,000 | +73.6% | 2,095,164 | +15.5% | 0.02% | +70.0% |
| Q1 2018 | $209,362,000 | +35.1% | 1,814,689 | -1.4% | 0.01% | +42.9% |
| Q4 2017 | $155,002,000 | -9.2% | 1,841,336 | -0.6% | 0.01% | -22.2% |
| Q3 2017 | $170,615,000 | +32.7% | 1,852,091 | +15.5% | 0.01% | +28.6% |
| Q2 2017 | $128,534,000 | +129.7% | 1,602,885 | +20.6% | 0.01% | +133.3% |
| Q1 2017 | $55,949,000 | +114081.6% | 1,329,594 | +86631.5% | 0.00% | – |
| Q4 2016 | $49,000 | +19.5% | 1,533 | -2.1% | 0.00% | – |
| Q3 2016 | $41,000 | +141.2% | 1,566 | +119.0% | 0.00% | – |
| Q2 2016 | $17,000 | +88.9% | 715 | +122.7% | 0.00% | – |
| Q1 2016 | $9,000 | – | 321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |